← All stocks

Charles River Laboratories

CRL Net selling
CIK 0001100682 #101 in the set updated 17 Sep 2026
Bought (120 mo)
$5.10M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$317.49M
$24.62M on a plan · $174.11M straight out of an exercise
Sold at will
$118.76M
1895 of 3071 sales
Net
−$312.39M
−$113.66M against sales at will

By person

33 insiders · 3,085 transactions
8.0×

James C. Foster holds 8.0 times base salary in stock. $12.48M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what James C. Foster last reported holding, valued at $300.00, the price Common Stock was last bought or sold at on the open market here, on 25 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FOSTER JAMES C
Director
$2.00M (2)
$174.71M (1545) scheduled
−$172.71M
41,596
0.0871%
$12.48M
−69.8%
Smith David Ross
Corporate Executive VP & CFO
$22.86M (427) scheduled
−$22.86M
25,819
0.0541%
$7.75M
+147.6%
Barbo William D
Corporate Executive VP & CCO
$19.46M (204) scheduled
−$19.46M
26,770
0.0561%
$8.03M
+61.3%
LaPlume Joseph W
EVP, Corp Strategy & Develop
$4.36K (1)
$16.48M (106) scheduled
−$16.48M
31,041
0.0650%
$9.31M
+139.0%
JOHST DAVID P
Corporate Executive VP
$14.28M (73) scheduled
−$14.28M
224,478
0.4702%
$67.34M
+39.6%
Girshick Birgit
Chief Executive Officer
$497.55K (2)
$14.31M (157) scheduled
−$13.81M
79,288
0.1661%
$23.79M
+243.0%
Molho Davide
President & COO
$10.83M (106) scheduled
−$10.83M
64,172
0.1344%
$19.25M
+10.1%
Parisotto Shannon M
CEVP, Disc & Safety Assessment
$7.07M (24) scheduled
−$7.07M
14,487
0.0303%
$4.35M
+382.9%
Creamer Victoria L
EVP & Chief People Officer
$6.47M (4) scheduled
−$6.47M
30,051
0.0629%
$9.02M
+421.7%
Knell Michael Gunnar
SVP, Finance and CAO
$4.84M (19) scheduled
−$4.84M
11,852
0.0248%
$3.56M
+1,380%
MASSARO GEORGE
Director
$4.78M (157) scheduled
−$4.78M
5,575
0.0117%
$1.67M
−40.8%
MILNE GEORGE M JR
Director
$4.75M (5) scheduled
−$4.75M
29,079
0.0609%
$8.72M
+43.2%
BERTOLINI ROBERT J
Director
$4.35M (142) scheduled
−$4.35M
32,802
0.0687%
$9.84M
+62.8%
Kochevar Deborah Turner
Director
$3.09M (58) scheduled
−$3.09M
7,894
0.0165%
$2.37M
−23.2%
WALLMAN RICHARD F
Director
$2.59M (5)
$5.60M (9)
−$3.01M
12,386
0.0259%
$3.72M
+317.5%
CHUBB STEPHEN D
Director
$2.08M (31) scheduled
−$2.08M
40,529
0.0849%
$12.16M
+120.5%
REESE C RICHARD
Director
$1.37M (3) scheduled
−$1.37M
65,541
0.1373%
$19.66M
+91.5%
Andrews Nancy C
Director
$163.44K (1) scheduled
−$163.44K
5,402
0.0113%
$1.62M
Coleman Glenn
EVP & Chief Financial Officer
27,752
0.0581%
$8.33M
Pease Flavia
Corporate Executive VP & CFO
17,297
0.0362%
$5.19M
MACKAY MARTIN
Director
17,137
0.0359%
$5.14M
Mintz Mark
EVP, Chief Information Officer
9,546
0.0200%
$2.86M
+50.3%
Llado George Sr.
Director
6,702
0.0140%
$2.01M
WILSON VIRGINIA M
Director
6,349
0.0133%
$1.90M
Crowley John J
SVP, Chief Accounting Officer
5,599
0.0117%
$1.68M
−4.8%
Kemps-Polanco Reshema
Director
4,563
0.0096%
$1.37M
Mangeolle Jean-Paul
Director
3,886
0.0081%
$1.17M
Thompson Craig B.
Director
3,851
0.0081%
$1.16M
Barg Steven
Director
3,287
0.0069%
$986.10K
KUO JOHN W
CEVP General Counsel & CCO
3,171
0.0066%
$951.30K
Graves Paul W
Director
2,384
0.0050%
$715.20K
Ceesay Abraham
Director
2,384
0.0050%
$715.20K
Enyedy Mark J
Director
2,384
0.0050%
$715.20K
Insider
Date
Role
Action
Shares
Price
Amount
LaPlume Joseph W
3 Mar 2026
EVP, Corp Strategy & Develop
Buy
25
$174.54
$4.36K
Girshick Birgit
20 Feb 2025
Corporate Executive VP & COO
Buy
1,514
$164.63
$249.25K
FOSTER JAMES C
20 Feb 2025
Chairman, President and CEO
Buy
6,075
$165.01
$1.00M
Girshick Birgit
20 Nov 2023
Corporate Executive VP & COO
Buy
1,322
$187.82
$248.30K
FOSTER JAMES C
14 Nov 2023
Chairman, President and CEO
Buy
5,620
$178.05
$1.00M
WALLMAN RICHARD F
24 Aug 2023
Director
Buy indirect
1,000
$198.79
$198.79K
WALLMAN RICHARD F
23 Feb 2023
Director
Buy
1,750
$220.73
$386.28K
WALLMAN RICHARD F
2 Dec 2022
Director
Buy
1,500
$218.90
$328.35K
Showing 250 of 3,085 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 633
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 1,161
Sales at will 1,895
Transactions with no price 0
Shares from compensation/vesting 3,858,440
Sales filed before the plan box existed 1,872
History held since 1 Sep 2016